Cambridge Investment Research Advisors »

Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Cambridge Investment Research Advisors

Quarter-by-quarter ownership of Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Cambridge Investment Research Advisors from 13F filings

Historical chart of Cambridge Investment Research Advisors investment in Sarepta Therapeutics Inc Note 1.250 9/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics Inc Note 1.250 9/1 held by Cambridge Investment Research Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics Inc Note 1.250 9/1 by Cambridge Investment Research Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $12k 13k 0.92

More positions owned by Cambridge Investment Research Advisors

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple Inc Com (AAPL)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds Total Stk Mkt (VTI)
Amazon Com Inc Com (AMZN)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Microsoft Corp Com (MSFT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Capital Group Dividend Value Shs Creation Uni (CGDV)
Alphabet Inc Cap Stk Cl A (GOOGL)
Alphabet Inc Cap Stk Cl C (GOOG)
SPDR Gold Tr Gold Shs (GLD)

View all positions for Cambridge Investment Research Advisors

Top funds holding Sarepta Therapeutics Inc Note 1.250 9/1

Jpmorgan Chase & Co
Highbridge Capital Management
DG Capital Management
D. E. Shaw & Co
LMR Partners
Calamos Advisors
Corbyn Investment Management
Bnp Paribas Investment Partners
State of Wisconsin Investment Board
Palisade Capital Management
FMR
Advent Capital Management
Financial Consulate
Morgan Stanley
HB Wealth Management

View all funds holding Sarepta Therapeutics Inc Note 1.250 9/1